USC.edu
Are You a Patient?

Manju Aron, MD

Professor of Clinical Pathology and Urology

GU Service Line Director

Image of Manju Aron, MD
Is this your profile? Click to edit
Phone +1 323 409 4614
Email [email protected]
CTSI Profile

Publications

  • Mucinous Borderline Tumors of the Pelvicalyceal System: Report of Two Tumors With Molecular Findings and Review of Literature. Int J Surg Pathol. 2025 Jun; 33(4):1022-1028.. View in PubMed
  • SS18-SSX Expression and Clinicopathologic Profiles in a Contemporary Cohort of Primary Paratesticular Synovial Sarcoma: A Series of Fourteen Patients. Am J Surg Pathol. 2025 Jan 01; 49(1):11-19.. View in PubMed
  • A sustainable and expedited ‘One-Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility. BJUI Compass. 2024 Dec; 5(12):1278-1287.. View in PubMed
  • Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. Virchows Arch. 2024 Nov; 485(5):829-840.. View in PubMed
  • Transperineal versus Transrectal MRI/TRUS fusion-guided prostate biopsy in a large, ethnically diverse, and multiracial cohort. Int Braz J Urol. 2024 Sep-Oct; 50(5):616-628.. View in PubMed
  • The learning curve for transperineal MRI/TRUS fusion prostate biopsy: A prospective evaluation of a stepwise approach. Urol Oncol. 2025 01; 43(1):64.e1-64.e10.. View in PubMed
  • Advances, recognition, and interpretation of molecular heterogeneity among conventional and subtype histology of urothelial carcinoma (UC): a survey among urologic pathologists and comprehensive review of the literature. Histopathology. 2024 Nov; 85(5):748-759.. View in PubMed
  • A nomogram to predict the absence of clinically significant prostate cancer in males with negative MRI Int Braz J Urol. 2024 May-Jun; 50(3):319-334. Kaneko M , Fujihara A, Iwata T, Ramacciotti LS, Pal . View in PubMed
  • Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK-RAS Pathway. Mod Pathol. 2024 06; 37(6):100492.. View in PubMed
  • Prostatic adenocarcinoma: molecular underpinnings and treatment-related options. Urol Oncol. 2024 07; 42(7):203-210.. View in PubMed

Similar People